Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Aug
6
2014
Medical Device Update: FDA Issues Final Guidance on 510(k) Determinations, Use of “Split” Predicates Strongly Discouraged Morgan, Lewis & Bockius LLP
Aug
6
2014
D.C. Circuit Rejects Toxic Tort Claims Based on Aerial Spraying of Herbicide Beveridge & Diamond PC
Aug
5
2014
Summary Of FDA Advertising and Promotion Enforcement Activities Covington & Burling LLP
Aug
5
2014
The Electronic Wallet System: How Nigeria Is Dialing Into Its Agricultural Sector Covington & Burling LLP
Aug
4
2014
Ignorance is Bliss – for Teva re: Structural Obviousness in Patent Cases
Aug
4
2014
Commission Updates EU Medical Devices Borderline Manual Covington & Burling LLP
Aug
4
2014
FDA Issues Updated Draft Guidance on Reporting Drug Samples Morgan, Lewis & Bockius LLP
Aug
3
2014
EcoWater Systems LLC v. Culligan International Co., Inter Partes Review Still Difficult for Patent Owners McDermott Will & Emery
Aug
3
2014
Dissent at the Patent Trial and Appeal Board (PTAB) Leads to … Unpatentability McDermott Will & Emery
Aug
2
2014
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc., Denying Institution IPR2014-00361 Faegre Drinker
Aug
1
2014
What’s New Under the Food Safety Modernization Act? Beveridge & Diamond PC
Jul
31
2014
FDA Releases Details of New Framework for Laboratory Developed Tests Regulation Morgan, Lewis & Bockius LLP
Jul
31
2014
FDA Finalizes Appeals Guidance on Section 517A of the Food, Drug, and Cosmetic Act Covington & Burling LLP
Jul
31
2014
USPTO TRIPs Over Myriad-Mayo Guidance - Trade-related Aspects of Intellectual Property Rights
Jul
31
2014
Contractual Duty to Deal Does Not Equal Antitrust Duty to Deal McDermott Will & Emery
Jul
31
2014
Energy Technology Connections - July 2014 Mintz
Jul
31
2014
Intelligent Bio-Systems, Inc. v. Illumina Cambridge Limited, Final Written Decision IPR2013-00128 Faegre Drinker
Jul
31
2014
A Compound Is Obvious Where Only Minor Changes to a Prior Art “Lead Compound” Are Required to Make the Claimed Compound McDermott Will & Emery
Jul
30
2014
Obviousness Only Requires Reasonable Expectation of Success of One Compound Encompassed by Broad Genus Claims McDermott Will & Emery
Jul
30
2014
European Commission Fines Servier and Five Generic Companies for Preventing Entry of Generic Versions of Blood Pressure Control Drug Covington & Burling LLP
Jul
30
2014
The Race is on! Anxiously Waiting for the First U.S. Biosimilar to Cross the Finish Line Michael Best & Friedrich LLP
Jul
28
2014
FDA Finalizes Guidance on the Evaluation of 510(k) Substantial Equivalence Covington & Burling LLP
Jul
28
2014
FDA Denies Citizen Petition’s Request to Ban Marketing of Non-Absorbable Surgical Mesh Products for Transvaginal Repair of Pelvic Organ Prolapse Covington & Burling LLP
Jul
25
2014
The FDA’s Informed Consent Draft Guidance: Insights and Challenges for IRBs, Clinical Investigators and Sponsors Faegre Drinker
Jul
24
2014
FDA Accepts the First Biosimilar Application under the BPCIA (Biologics Price Competition and Innovation Act) Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
24
2014
Recent FDA Draft Guidance Addresses Social Media Challenges Faced by Drug and Device Companies Faegre Drinker
Jul
24
2014
China Releases New Notification Procedures for Class I Medical Devices Covington & Burling LLP
Jul
23
2014
Illinois Legislature Approves Medical Marijuana for Epileptic Adults and Children Heyl, Royster, Voelker & Allen, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins